Efficacy and Safety of Depemokimab (GSK3511294) in Participants With Chronic Rhinosinusitis With Nasal Polyps
Clinical trial NCT05274750 · COMPLETED
Trial details
- NCT number
- NCT05274750
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-22
- Primary completion
- 2024-07-30
- Enrollment
- 276
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.